Your browser doesn't support javascript.
loading
Uso de teduglutide en intestino corto secundario a enfermedad de Crohn en un paciente con terapia dual ustekinumab y vedolizumab / Use of teduglutide for short bowel syndrome and Crohn’s disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy
Martí Romero, Lidia; Peño Muñoz, Leura; Martínez Escapa, Vanesa; Hinojosa del Val, Joaquín.
Affiliation
  • Martí Romero, Lidia; Hospital Francesc de Borja. Digestive Diseases Service. Valencia. Spain
  • Peño Muñoz, Leura; Hospital Francesc de Borja. Digestive Diseases Service. Valencia. Spain
  • Martínez Escapa, Vanesa; Hospital Francesc de Borja. Digestive Diseases Service. Valencia. Spain
  • Hinojosa del Val, Joaquín; Universidad Católica de Valencia. Valencia. Spain
Rev. esp. enferm. dig ; 115(6): 331-332, 2023. ilus
Article in Es | IBECS | ID: ibc-221718
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Key words
Search on Google
Add to My VHL
Print
XML

Collection: 06-national / ES Database: IBECS Main subject: Short Bowel Syndrome / Biological Therapy / Gastrointestinal Agents / Crohn Disease / Ustekinumab Limits: Female / Humans Language: Es Journal: Rev. esp. enferm. dig Year: 2023 Document type: Article
Search on Google
Add to My VHL
Print
XML

Collection: 06-national / ES Database: IBECS Main subject: Short Bowel Syndrome / Biological Therapy / Gastrointestinal Agents / Crohn Disease / Ustekinumab Limits: Female / Humans Language: Es Journal: Rev. esp. enferm. dig Year: 2023 Document type: Article